- Home
- MRVI vs TVA Comparison
MRVI vs TVA Comparison
Compare MRVI & TVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRVI
- TVA
- Stock Information
- Founded
- MRVI 2014
- TVA 2024
- Country
- MRVI United States
- TVA United States
- Employees
- MRVI 560
- TVA N/A
- Industry
- MRVI Biotechnology: Pharmaceutical Preparations
- TVA
- Sector
- MRVI Health Care
- TVA
- Exchange
- MRVI Nasdaq
- TVA Nasdaq
- Market Cap
- MRVI 350.1M
- TVA 303.4M
- IPO Year
- MRVI 2020
- TVA 2025
- Fundamental
- Price
- MRVI $2.42
- TVA $10.13
- Analyst Decision
- MRVI Hold
- TVA
- Analyst Count
- MRVI 10
- TVA 0
- Target Price
- MRVI $5.84
- TVA N/A
- AVG Volume (30 Days)
- MRVI 1.5M
- TVA 32.0
- Earning Date
- MRVI 08-11-2025
- TVA 01-01-0001
- Dividend Yield
- MRVI N/A
- TVA N/A
- EPS Growth
- MRVI N/A
- TVA N/A
- EPS
- MRVI N/A
- TVA N/A
- Revenue
- MRVI $219,830,000.00
- TVA N/A
- Revenue This Year
- MRVI N/A
- TVA N/A
- Revenue Next Year
- MRVI $7.23
- TVA N/A
- P/E Ratio
- MRVI N/A
- TVA N/A
- Revenue Growth
- MRVI N/A
- TVA N/A
- 52 Week Low
- MRVI $1.67
- TVA $9.99
- 52 Week High
- MRVI $9.60
- TVA $10.34
- Technical
- Relative Strength Index (RSI)
- MRVI 49.60
- TVA N/A
- Support Level
- MRVI $2.28
- TVA N/A
- Resistance Level
- MRVI $2.47
- TVA N/A
- Average True Range (ATR)
- MRVI 0.14
- TVA 0.00
- MACD
- MRVI -0.01
- TVA 0.00
- Stochastic Oscillator
- MRVI 27.45
- TVA 0.00
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
About TVA Texas Ventures Acquisition III Corp Class A Ordinary Share
Texas Ventures Acquisition III Corp is a blank check company.